Drug Discovery Informatics Market Set to Surge at 10.9% CAGR, to Reach USD 6.8 billion by 2031 | Transparency Market Research, Inc.
January 10, 2024 04:06 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global drug discovery informatics market is estimated to flourish at a CAGR of 10.9%...
AI in Drug Discovery Market to Cross USD 10.93 billion by 2031, Garnering a 36.1% CAGR from 2021 to 2031 | TMR Study
November 10, 2023 03:05 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global AI in drug discovery market is projected to flourish at a CAGR of 36.1% from 2023...
Oligonucleotide API Market revenue to surpass USD 5 Billion by 2035, says Research Nester
September 27, 2023 06:07 ET
|
Research Nester
New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The global oligonucleotide API market size is projected to expand at ~ 10% CAGR between 2023 and 2035. The market is expected to garner a revenue of USD...
Clinical Trials Matching Software Market Size to Observe Highest Growth of USD 326.23 million with an Excellent CAGR of 13.50% by The End of 2028
January 17, 2023 11:00 ET
|
Markets N Research
Chicago, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Markets N Research has recently released expansive research on Global Clinical Trials Matching Software Market with 100+ market data Tables, Pie Chart, and...
Computer Aided Drug Discovery Market to Grow $7.5 Billion by 2030: Allied Market Research
July 04, 2022 08:58 ET
|
Allied Market Research
Portland, OR, July 04, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Computer Aided Drug Discovery Market generated $2.9 billion in 2021, and is...
Precision Medicine Software Market Worth $2.55 Billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®
September 15, 2021 09:30 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Sept. 15, 2021 (GLOBE NEWSWIRE) -- According to a new market research report, “Precision Medicine Software Market by Deployment Mode (On-premise, Cloud-based), Application...
Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference
March 04, 2021 16:15 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts,...
Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market
February 01, 2021 17:16 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...
Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results
November 13, 2019 16:40 ET
|
Interpace Biosciences, Inc.
Third Quarter Revenue Grew 34% Over the Prior Year’s Quarter and 25% Year to Date Acquired BioPharma Business in Partnership with Ampersand Diagnostic Test Volume Grew 16% for the Quarter and...
Cancer Genetics, Inc. Announces Strategic Transactions
October 24, 2019 16:15 ET
|
Cancer Genetics, Inc.
Note Payment Received from Interpace Diagnostics Group, Inc. Settlement Agreement with NovellusDx Restructured Note Agreement with Unsecured Lender M&A Advisory Agreement with H.C....